SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics discovery, has partnered with Alamar Biosciences, a pioneer in ultra-sensitive and highly multiplexed immunoassay technologies, to extend ...
The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...
For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer treatments based upon DNA mutations in a tumor. Targeted therapies — often one pill ...
P-glycoprotein (P-gp) is a major membrane transporter associated with xenobiotic efflux that has been studied extensively in early drug development. Its level of expression influences the absorption ...
An illustration shows the structure of an inhibitor bound to the active site of membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase. An inhibitor bound to the active site of ...
Machine-learning platform enables signal peptide-informed discovery of small molecules that selectively inhibit protein secretion allowing for the degradation of disease-related proteins at the point ...
Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical settings ZURICH--(BUSINESS WIRE)--Biognosys, a ...
Researchers developed a forensic proteomics workflow that identified the species origin of hair using protein biomarkers ...
At this year's American Association for Cancer Research annual meeting, the conversation around cancer research felt noticeably different compared to the last time I attended. Genes and mutations were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results